226 results on '"Brenneman, Randall"'
Search Results
2. Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5
3. A Pilot Study of Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Online Adaptive Planning
4. Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy
5. Radiation-Induced Cardiac Dysfunction: Optimizing Radiation Delivery and Postradiation Care
6. Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer
7. Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer
8. Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer
9. Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer
10. Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
11. Reduced Wide Local Excision Margins are Associated with Increased Risk of Relapse and Death from Merkel Cell Carcinoma
12. Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer
13. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
14. Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
15. A Pilot Study of Simulation-Free Hippocampal-Avoidance Whole Brain Radiation Therapy Using Diagnostic MRI-Based and Online Adaptive Planning
16. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
17. Data from Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
18. Supplementary Figures 1 - 3 from Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
19. 4-1BB Aptamer-Based Immunomodulation Enhances the Therapeutic Index of Radiation Therapy in Murine Tumor Models
20. Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy
21. Supplementary Figures from Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation
22. Data from Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation
23. The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
24. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
25. PSOR9 Presentation Time: 12:10 PM
26. Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast Radiation
27. Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy
28. Reply by Authors
29. Generative adversarial neural networks augment marker and pathway analysis of treatment resistant HPV+ head and neck squamous cell carcinoma.
30. Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?
31. Risk Factors for Functional Outcomes in Advanced Laryngeal Squamous Cell Carcinoma
32. Outcomes of Unfavorable Intermediate-Risk Prostate Cancer Patients Treated with External Beam Radiotherapy vs. Brachytherapy Alone
33. Is the addition of brachytherapy and/or androgen deprivation therapy associated with improved overall survival in unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy?
34. Risk Factors for Functional Outcomes in Advanced Laryngeal Squamous Cell Carcinoma.
35. Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone
36. External beam radiation therapy with or without brachytherapy boost for low PSA, high-grade prostate cancer.
37. A Case of Gorham-Stout Disease of the Skull Base Treated With Intensity Modulated Radiation Therapy
38. A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
39. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
40. Regarding the Use of PSMA PET-CT Versus Conventional Imaging for Assessing the Value of Prophylactic Whole-Pelvis Radiation for High-Risk Prostate Cancer
41. Aptamer-mediated transcriptional gene silencing of Foxp3 inhibits regulatory T cells and potentiates antitumor response
42. Stereotactic body radiation therapy (SBRT) versus conventionally fractionated external beam radiation therapy in unfavorable intermediate-risk prostate cancer: An inverse propensity matched analysis.
43. PRSOR07 Presentation Time: 12:30 PM
44. Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning
45. Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma
46. PLEN02 Presentation Time: 1:30 PM
47. PRSOR01 Presentation Time: 12:00 PM
48. Neoadjuvant versus concurrent androgen deprivation therapy plus radiotherapy for unfavorable intermediate-risk and high-risk prostate cancer with low PSA.
49. Utilization and survival outcomes between definitive versus conservative treatments among elderly men with high-risk prostate cancer.
50. Regional lymph node irradiation in locally advanced Merkel cell carcinoma reduces regional and distant relapse and improves disease-specific survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.